Patterns of care and survival in patients with multifocal glioblastoma: a Danish cohort study

A. Trip, R. Hedegaard Dahlrot, Charlotte Aaquist Haslund, A. Muhic, Anders Rosendal Korshøj, René Johannes Laursen, F. Rom Poulsen, J. Skjøth-Rasmussen, S. Lukacova
{"title":"Patterns of care and survival in patients with multifocal glioblastoma: a Danish cohort study","authors":"A. Trip, R. Hedegaard Dahlrot, Charlotte Aaquist Haslund, A. Muhic, Anders Rosendal Korshøj, René Johannes Laursen, F. Rom Poulsen, J. Skjøth-Rasmussen, S. Lukacova","doi":"10.1093/nop/npae020","DOIUrl":null,"url":null,"abstract":"\n \n \n This Danish cohort study aims to (1) compare patterns of care (POC) and survival of patients with multifocal glioblastoma (mGBM) to those with unifocal glioblastoma (uGBM), and (2) explore the association of patient-related factors with treatment assignment and prognosis, respectively, in the subgroup of mGBM patients.\n \n \n \n Data on all adults with newly diagnosed, pathology-confirmed GBM between 2015-2019 was extracted from the Danish Neuro-Oncology Registry. To compare POC and survival of mGBM to uGBM, we applied multivariable logistic and Cox regression analysis, respectively. To analyze the association of patient-related factors with treatment assignment and prognosis, we established multivariable logistic and Cox regression models, respectively.\n \n \n \n In this cohort of 1343 patients, 231 had mGBM. Of those, 42% underwent tumor resection and 41% were assigned to long-course chemoradiotherapy. Compared to uGBM, mGBM patients less often underwent a partial (OR 0.4, 95%CI 0.2-0.6), near total (OR 0.1, 95%CI 0.07-0.2), and complete resection (OR 0.1, 95%CI 0.07-0.2) vs biopsy. mGBM patients were furthermore less often assigned to long-course chemoradiotherapy (OR 0.6, 95%CI 0.4-0.97). Median overall survival was 7.0 (95% CI 5.7-8.3) months for mGBM patients, and multifocality was an independent poor prognostic factor for survival (HR 1.3, 95%CI 1.1-1.5). In mGBM patients, initial performance, O[6]-methylguanine-DNA methyltransferase (MGMT) promotor methylation status, and extent of resection were significantly associated with survival.\n \n \n \n Patients with mGBM were treated with an overall less intensive approach. Multifocality was a poor prognostic factor for survival with a moderate effect. Prognostic factors for patients with mGBM were identified.\n","PeriodicalId":506567,"journal":{"name":"Neuro-Oncology Practice","volume":"47 4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuro-Oncology Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/nop/npae020","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

This Danish cohort study aims to (1) compare patterns of care (POC) and survival of patients with multifocal glioblastoma (mGBM) to those with unifocal glioblastoma (uGBM), and (2) explore the association of patient-related factors with treatment assignment and prognosis, respectively, in the subgroup of mGBM patients. Data on all adults with newly diagnosed, pathology-confirmed GBM between 2015-2019 was extracted from the Danish Neuro-Oncology Registry. To compare POC and survival of mGBM to uGBM, we applied multivariable logistic and Cox regression analysis, respectively. To analyze the association of patient-related factors with treatment assignment and prognosis, we established multivariable logistic and Cox regression models, respectively. In this cohort of 1343 patients, 231 had mGBM. Of those, 42% underwent tumor resection and 41% were assigned to long-course chemoradiotherapy. Compared to uGBM, mGBM patients less often underwent a partial (OR 0.4, 95%CI 0.2-0.6), near total (OR 0.1, 95%CI 0.07-0.2), and complete resection (OR 0.1, 95%CI 0.07-0.2) vs biopsy. mGBM patients were furthermore less often assigned to long-course chemoradiotherapy (OR 0.6, 95%CI 0.4-0.97). Median overall survival was 7.0 (95% CI 5.7-8.3) months for mGBM patients, and multifocality was an independent poor prognostic factor for survival (HR 1.3, 95%CI 1.1-1.5). In mGBM patients, initial performance, O[6]-methylguanine-DNA methyltransferase (MGMT) promotor methylation status, and extent of resection were significantly associated with survival. Patients with mGBM were treated with an overall less intensive approach. Multifocality was a poor prognostic factor for survival with a moderate effect. Prognostic factors for patients with mGBM were identified.
多灶性胶质母细胞瘤患者的护理模式和存活率:丹麦队列研究
这项丹麦队列研究旨在:(1)比较多灶性胶质母细胞瘤(mGBM)患者与单灶性胶质母细胞瘤(uGBM)患者的治疗模式(POC)和生存率;(2)探讨患者相关因素分别与多灶性胶质母细胞瘤患者亚组的治疗分配和预后的关系。 从丹麦神经肿瘤登记处提取了2015-2019年间所有新诊断、病理确诊的GBM成人患者的数据。为了比较 mGBM 和 uGBM 的 POC 和生存率,我们分别采用了多变量逻辑分析和 Cox 回归分析。为了分析患者相关因素与治疗分配和预后的关系,我们分别建立了多变量逻辑和Cox回归模型。 在这组 1343 名患者中,231 人患有 mGBM。其中,42%的患者接受了肿瘤切除术,41%的患者接受了长程化放疗。与 uGBM 相比,mGBM 患者较少接受部分切除(OR 0.4,95%CI 0.2-0.6)、近全切除(OR 0.1,95%CI 0.07-0.2)和完全切除(OR 0.1,95%CI 0.07-0.2)与活检。mGBM患者的中位总生存期为7.0个月(95% CI 5.7-8.3个月),多灶性是影响生存期的独立不良预后因素(HR 1.3,95%CI 1.1-1.5)。在mGBM患者中,初始表现、O[6]-甲基鸟嘌呤-DNA甲基转移酶(MGMT)启动子甲基化状态和切除范围与生存率显著相关。 mGBM患者接受的治疗总体上强度较低。多灶性是生存率较差的预后因素,但影响不大。确定了mGBM患者的预后因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信